J
John G.F. Cleland
Researcher at National Institutes of Health
Publications - 1276
Citations - 125527
John G.F. Cleland is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 137, co-authored 1172 publications receiving 110227 citations. Previous affiliations of John G.F. Cleland include Northwestern University & Imperial College London.
Papers
More filters
Journal ArticleDOI
NHS Heart Failure Survey - a survey of acute heart failure admissions in England, Wales and Northern Ireland
Edward D. Nicol,Barbara Fittall,Michael Roughton,John G.F. Cleland,Henry J. Dargie,Martin R. Cowie +5 more
TL;DR: Many patients admitted to acute hospitals in England, Wales and Northern Ireland are not being managed fully in accordance with international evidence-based guidelines, and women seem to be less well managed against recommended guidelines.
Journal ArticleDOI
Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.
TL;DR: It is important to organise care structures to ensure that patients with post-MI heart failure and LVSD are identified and managed appropriately.
Journal ArticleDOI
Links between premarital sexual behaviour and extramarital intercourse: a multi-site analysis.
TL;DR: Characteristics of premarital conduct such as age at sexual debut, length of acquaintance with debut partner and number of pre marital partners were significantly associated with EMI in men later in life.
Journal ArticleDOI
Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure.
Pierpaolo Pellicori,Pierpaolo Pellicori,Parin Shah,Joseph J Cuthbert,Alessia Urbinati,Jufen Zhang,Jufen Zhang,Anna Kallvikbacka-Bennett,Andrew L. Clark,John G.F. Cleland,John G.F. Cleland +10 more
TL;DR: Even if treatment controls symptoms, patients with heart failure may still be congested, and the prevalence and clinical relevance of congestion in outpatients with chronic heart failure is investigated.
Journal ArticleDOI
Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET.
Philip A. Poole-Wilson,John G.F. Cleland,Andrea Di Lenarda,Peter Hanrath,Michel Komajda,Marco Metra,Willem J. Remme,Karl Swedberg,Christian Torp-Pedersen +8 more
TL;DR: The rationale, design and possible outcomes of COMET are outlined, which is the first study to investigate whether beta‐blocking agents with differing pharmacological profiles exert different effects on morbidity and mortality in patients with chronic heart failure.